Skip to main content
Erschienen in: Clinical Rheumatology 11/2020

06.05.2020 | Original Article

Etiologies and outcomes of rheumatology patients with acute respiratory failure requiring intensive care: a single-center medical records review study of 259 patients

verfasst von: Yan Shi, Bin Du, Jiu-Liang Zhao, Han-Yu Qin, Xiao-Yun Hu, Wei Jiang, Chun-Yao Wang, Li Weng, Qian Wang, Xiao-Feng Zeng, Jin-Min Peng

Erschienen in: Clinical Rheumatology | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

The etiologies of acute respiratory failure in patients with systemic rheumatic diseases (SRDs) requiring intensive care remain unknown. This study was undertaken to investigate the etiologies and outcomes.

Methods

A medical records review study was performed of 259 adult SRDs patients with respiratory failure admitted to medical ICU across a 5-year period. The etiologies were classified as infection, SRD exacerbation, and undetermined. The factors associated with ICU mortality were identified with multivariate logistic regression analysis.

Results

The etiologies of respiratory failure included infection (n = 209, 80.7%), SRD exacerbation (n = 71, 27.4%), and undetermined (n = 21, 8.1%). The most common pathogen was Pneumocystis jirovecii (39.8%), followed by Aspergillus spp. (33.2%), and cytomegalovirus (23.2%). The ICU mortality rate was 59.8%. A high acute physiology and chronic health evaluation II score (OR 1.118, 95% CI 1.054 to 1.186, p < 0.001), a PaO2/FiO2 ratio < 100 mmHg (OR 3.918, 95% CI 2.199 to 6.892, p < 0.001), and a diagnosis of dermatomyositis/polymyositis (OR 4.898, 95% CI 1.949 to 12.309, p = 0.001), vasculitis (OR 3.007, 95% CI 1.237 to 7.309, p = 0.015), and Pneumocystis pneumonia (OR 2.345, 95% CI 1.168 to 4.705, p = 0.016) were associated with increased mortality.

Conclusions

Opportunistic infections and SRD exacerbation were the most common etiologies of acute respiratory failure in patients with SRDs requiring ICU admission, with high ICU mortality. Development of a standard protocol for differential diagnosis in this population might help initiate definitive therapy and improve clinical outcome.
Key Points
• Infections, especially with opportunistic infections, were the leading cause of acute respiratory failure in critically ill rheumatology patients, with high mortality.
• Severity of illness, certain types of rheumatic diseases, and opportunistic fungal infections were associated with increased mortality.
• Using a comprehensive diagnostic workup might help to confirm the infective etiology and improve outcome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729–748CrossRefPubMed Janssen NM, Karnad DR, Guntupalli KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729–748CrossRefPubMed
2.
Zurück zum Zitat Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Filippatos G, Bouros D (2016) Acute respiratory events in connective tissue disorders. Respiration 91:181–201CrossRefPubMed Papiris SA, Manali ED, Kolilekas L, Kagouridis K, Maniati M, Filippatos G, Bouros D (2016) Acute respiratory events in connective tissue disorders. Respiration 91:181–201CrossRefPubMed
3.
Zurück zum Zitat Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau C, Brechot N, Duprey M, Mayaux J, Schenck M, Boisramé-Helms J, Thomas G, Baboi L, Mouthon L, Amoura Z, Papo T, Mahr A, Chevret S, Chiche JD, Azoulay E (2015) Outcomes in critically ill patients with rheumatic disease: a multicenter study. Chest 148:927–935CrossRefPubMed Dumas G, Géri G, Montlahuc C, Chemam S, Dangers L, Pichereau C, Brechot N, Duprey M, Mayaux J, Schenck M, Boisramé-Helms J, Thomas G, Baboi L, Mouthon L, Amoura Z, Papo T, Mahr A, Chevret S, Chiche JD, Azoulay E (2015) Outcomes in critically ill patients with rheumatic disease: a multicenter study. Chest 148:927–935CrossRefPubMed
4.
Zurück zum Zitat Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, Anaya JM (2005) Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 14:315–320CrossRefPubMed Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, Anaya JM (2005) Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus 14:315–320CrossRefPubMed
5.
Zurück zum Zitat Moreels M, Mélot C, Leeman M (2005) Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 31:591–593CrossRefPubMed Moreels M, Mélot C, Leeman M (2005) Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit. Intensive Care Med 31:591–593CrossRefPubMed
6.
Zurück zum Zitat Cavallasca JA, Del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A et al (2010) Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol 16:400–402CrossRefPubMed Cavallasca JA, Del Rosario Maliandi M, Sarquis S, Nishishinya MB, Schvartz A, Capdevila A et al (2010) Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit. J Clin Rheumatol 16:400–402CrossRefPubMed
7.
Zurück zum Zitat Lee J, Yim J, Yang S, Yoo C, Kim YW, Han SK, Lee EY, Lee EB, Song YW, Lee SM (2012) Outcomes of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int 32:3353–3358CrossRefPubMed Lee J, Yim J, Yang S, Yoo C, Kim YW, Han SK, Lee EY, Lee EB, Song YW, Lee SM (2012) Outcomes of patients with connective tissue disease requiring intensive care for respiratory failure. Rheumatol Int 32:3353–3358CrossRefPubMed
8.
Zurück zum Zitat Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E et al (2013) Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med 24(e):40–44CrossRef Faguer S, Ciroldi M, Mariotte E, Galicier L, Rybojad M, Canet E et al (2013) Prognostic contributions of the underlying inflammatory disease and acute organ dysfunction in critically ill patients with systemic rheumatic diseases. Eur J Intern Med 24(e):40–44CrossRef
9.
Zurück zum Zitat Wang M, Su S, Lv J, Zhou G, Wang Q, Guo C (2018) Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit. Egypt Rheumatol 40:63–66CrossRef Wang M, Su S, Lv J, Zhou G, Wang Q, Guo C (2018) Analysis of clinical features and prognostic factors in Chinese patients with rheumatic diseases in an intensive care unit. Egypt Rheumatol 40:63–66CrossRef
10.
Zurück zum Zitat Weng L, Huang X, Chen L, Feng LQ, Jiang W, Hu XY et al (2016) Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study. BMC Infect Dis 16:528CrossRefPubMedPubMedCentral Weng L, Huang X, Chen L, Feng LQ, Jiang W, Hu XY et al (2016) Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective study. BMC Infect Dis 16:528CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY, Yu CL, Yang PC (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 9:R177–R183CrossRefPubMedPubMedCentral Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY, Yu CL, Yang PC (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care 9:R177–R183CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Peng J, Du B, Wang Q, Weng L, Hu XY, Wu CY, Shi Y (2016) Dermatomyositis and polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS One 11:e0154441CrossRefPubMedPubMedCentral Peng J, Du B, Wang Q, Weng L, Hu XY, Wu CY, Shi Y (2016) Dermatomyositis and polymyositis in the intensive care unit: a single-center retrospective cohort study of 102 patients. PLoS One 11:e0154441CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Fauci A, Langford CA (2008) Allergy, clinical immunology and rheumatology. In: Fauci A (ed) Harrison’s principles of internal medicine, 17th edn. New York, McGraw-Hill Medical, pp 885–915 Fauci A, Langford CA (2008) Allergy, clinical immunology and rheumatology. In: Fauci A (ed) Harrison’s principles of internal medicine, 17th edn. New York, McGraw-Hill Medical, pp 885–915
14.
Zurück zum Zitat Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533PubMed Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533PubMed
15.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRefPubMed
16.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMed
17.
Zurück zum Zitat Shi Y, Rui X, Xie XL, Zhang XJ, Tang B, Liu Y, Zhao H (2013) Effect of diagnostic protocols on etiology and outcome in immunocompromised host with pulmonary infiltrate. Zhonghua Yi Xue Za Zhi 93:684–689PubMed Shi Y, Rui X, Xie XL, Zhang XJ, Tang B, Liu Y, Zhao H (2013) Effect of diagnostic protocols on etiology and outcome in immunocompromised host with pulmonary infiltrate. Zhonghua Yi Xue Za Zhi 93:684–689PubMed
18.
Zurück zum Zitat Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63(Suppl 5):v1–v58PubMed Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al (2008) Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 63(Suppl 5):v1–v58PubMed
19.
Zurück zum Zitat Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, Oriola S, Ramsey KM, Salgado CD, Weinstein RA, Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee (2008) Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 29:901–913CrossRefPubMed Cohen AL, Calfee D, Fridkin SK, Huang SS, Jernigan JA, Lautenbach E, Oriola S, Ramsey KM, Salgado CD, Weinstein RA, Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee (2008) Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 29:901–913CrossRefPubMed
20.
Zurück zum Zitat De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821CrossRefPubMed De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821CrossRefPubMed
21.
Zurück zum Zitat Harigai M, Koike R, Miyasaka N, Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group (2007) Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 357:1874–1876CrossRefPubMed Harigai M, Koike R, Miyasaka N, Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group (2007) Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med 357:1874–1876CrossRefPubMed
22.
Zurück zum Zitat Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L et al (2018) The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102:900–931CrossRefPubMed Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L et al (2018) The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102:900–931CrossRefPubMed
23.
Zurück zum Zitat Anaya JM, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA, Espinoza LR (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254CrossRefPubMed Anaya JM, Diethelm L, Ortiz LA, Gutierrez M, Citera G, Welsh RA, Espinoza LR (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24:242–254CrossRefPubMed
24.
Zurück zum Zitat Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157:1658–1665CrossRefPubMed Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157:1658–1665CrossRefPubMed
25.
Zurück zum Zitat Doyle JJ, Eliasson AH, Argyros GJ, Dennis GJ, Finger DR, Hurwitz KM, Phillips YY (2000) Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis. Clin Rheumatol 19:217–221CrossRefPubMed Doyle JJ, Eliasson AH, Argyros GJ, Dennis GJ, Finger DR, Hurwitz KM, Phillips YY (2000) Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis. Clin Rheumatol 19:217–221CrossRefPubMed
26.
Zurück zum Zitat Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789CrossRefPubMed Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789CrossRefPubMed
27.
Zurück zum Zitat Wolfe RM, Peacock JE Jr (2017) Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented? Curr Rheumatol Rep 19:35CrossRefPubMed Wolfe RM, Peacock JE Jr (2017) Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented? Curr Rheumatol Rep 19:35CrossRefPubMed
28.
Zurück zum Zitat Sowden E, Carmichael AJ (2004) Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis 4:42CrossRefPubMedPubMedCentral Sowden E, Carmichael AJ (2004) Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention. BMC Infect Dis 4:42CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663–670CrossRefPubMed Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26:663–670CrossRefPubMed
30.
Zurück zum Zitat Bienvenu A-L, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11–17CrossRefPubMed Bienvenu A-L, Traore K, Plekhanova I, Bouchrik M, Bossard C, Picot S (2016) Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients. Int J Infect Dis 46:11–17CrossRefPubMed
32.
Zurück zum Zitat Boonsarngsuk V, Sirilak S, Kiatboonsri S (2009) Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis 13:59–66CrossRefPubMed Boonsarngsuk V, Sirilak S, Kiatboonsri S (2009) Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int J Infect Dis 13:59–66CrossRefPubMed
33.
Zurück zum Zitat Kim SJ, Lee J, Cho YJ, Park YS, Lee CH, Yoon HI et al (2014) Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection. J Inf Secur 69:88–95 Kim SJ, Lee J, Cho YJ, Park YS, Lee CH, Yoon HI et al (2014) Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection. J Inf Secur 69:88–95
34.
Zurück zum Zitat Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9:e98824CrossRefPubMedPubMedCentral Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y et al (2014) Prognostic factors for myositis-associated interstitial lung disease. PLoS One 9:e98824CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M, Colby TV (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101:1761–1769CrossRefPubMed Won Huh J, Soon Kim D, Keun Lee C, Yoo B, Bum Seo J, Kitaichi M, Colby TV (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101:1761–1769CrossRefPubMed
36.
Zurück zum Zitat Chen IJ, Tsai WP, Wu YJ, Luo SF, Ho HH, Liou LB, Chen JY, Kuo CF, Chang HC, Yang CH, Yu KH (2010) Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford) 49:2429–2437CrossRef Chen IJ, Tsai WP, Wu YJ, Luo SF, Ho HH, Liou LB, Chen JY, Kuo CF, Chang HC, Yang CH, Yu KH (2010) Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford) 49:2429–2437CrossRef
37.
Zurück zum Zitat Chen M, Tian X, Qin F, Zhou J, Liu J, Wang M et al (2015) Pneumocystis pneumonia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death. PLoS One 10:e0139144CrossRefPubMedPubMedCentral Chen M, Tian X, Qin F, Zhou J, Liu J, Wang M et al (2015) Pneumocystis pneumonia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death. PLoS One 10:e0139144CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, Maubon D, Debourgogne A, le Gal S, Dalle F, Leterrier M, Toubas D, Pomares C, Bellanger AP, Bonhomme J, Berry A, Durand-Joly I, Magne D, Pons D, Hennequin C, Maury E, Roux P, Azoulay É (2014) Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis 20:1490–1497CrossRefPubMedPubMedCentral Roux A, Canet E, Valade S, Gangneux-Robert F, Hamane S, Lafabrie A, Maubon D, Debourgogne A, le Gal S, Dalle F, Leterrier M, Toubas D, Pomares C, Bellanger AP, Bonhomme J, Berry A, Durand-Joly I, Magne D, Pons D, Hennequin C, Maury E, Roux P, Azoulay É (2014) Pneumocystis jirovecii pneumonia in patients with or without AIDS, France. Emerg Infect Dis 20:1490–1497CrossRefPubMedPubMedCentral
Metadaten
Titel
Etiologies and outcomes of rheumatology patients with acute respiratory failure requiring intensive care: a single-center medical records review study of 259 patients
verfasst von
Yan Shi
Bin Du
Jiu-Liang Zhao
Han-Yu Qin
Xiao-Yun Hu
Wei Jiang
Chun-Yao Wang
Li Weng
Qian Wang
Xiao-Feng Zeng
Jin-Min Peng
Publikationsdatum
06.05.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 11/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05080-w

Weitere Artikel der Ausgabe 11/2020

Clinical Rheumatology 11/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.